Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 |
filingDate |
2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92ef4bc5768a8d1a65f9a08889320862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75c66968dc0f97cfed8ff3d2bfdc4ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99469077d6f3250272289efccbc7ab34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cc0e33675db34fd640c37cea5b950e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a009e4115504dfe88a894854efb3c5c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7959e348e90be45d8c1dc38bb71dc3df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a5b7197095325d4ad2ffa6b6f66ac5 |
publicationDate |
2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9738689-B2 |
titleOfInvention |
Prefusion RSV F proteins and their use |
abstract |
Disclosed are immunogens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the immunogens and methods of producing the immunogens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the immunogen to the subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541105-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485759-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732011-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771755-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267848-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023144665-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192926-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022002351-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022119454-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021014385-A1 |
priorityDate |
2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |